• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

4 型家族性部分性脂肪营养不良的肾脏表现:病例报告及文献复习。

The renal manifestations of type 4 familial partial lipodystrophy: a case report and review of literature.

机构信息

Department of Internal Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China.

Department of Nephrology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China.

出版信息

BMC Nephrol. 2018 May 10;19(1):111. doi: 10.1186/s12882-018-0913-6.

DOI:10.1186/s12882-018-0913-6
PMID:29747582
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5946515/
Abstract

BACKGROUND

Lipodystrophy syndromes are rare disorders of variable body fat loss associated with potentially serious metabolic complications. Familial partial lipodystrophy (FPLD) is mostly inherited as an autosomal dominant disorder. Renal involvement has only been reported in a limited number of cases of FPLD. Herein, we present a rare case of proteinuria associated with type 4 FPLD, which is characterized by a heterozygous mutation in PLIN1 and has not been reported with renal involvement until now.

CASE PRESENTATION

A 15-year-old girl presented with insulin resistance, hypertriglyceridaemia, hepatic steatosis and proteinuria. Her glucose and glycated haemoglobin levels were within normal laboratory reference ranges. A novel heterozygous frameshift mutation in PLIN1 was identified in the patient and her mother. The kidney biopsy showed glomerular enlargement and focal segmental glomerulosclerosis under light microscopy; the electron microscopy results fit with segmental thickening of the glomerular basement membrane. Treatment with an angiotensin-converting enzyme inhibitor (ACEI) decreased 24-h protein excretion.

CONCLUSIONS

We report the first case of proteinuria and renal biopsy in a patient with FPLD4. Gene analysis demonstrated a novel heterozygous frameshift mutation in PLIN1 in this patient and her mother. Treatment with ACEI proved to be beneficial.

摘要

背景

脂肪营养不良综合征是一种罕见的体脂丧失疾病,与潜在的严重代谢并发症有关。家族性部分脂肪营养不良(FPLD)主要以常染色体显性遗传方式遗传。肾脏受累仅在少数 FPLD 病例中报道过。在此,我们报告了一例与 4 型 FPLD 相关的蛋白尿罕见病例,其特征是 PLIN1 中的杂合性移码突变,迄今为止尚未报道与肾脏受累有关。

病例介绍

一名 15 岁女孩因胰岛素抵抗、高三酰甘油血症、肝脂肪变性和蛋白尿就诊。她的血糖和糖化血红蛋白水平均在正常实验室参考范围内。在患者及其母亲中发现了 PLIN1 中的新型杂合性移码突变。肾脏活检显示光镜下肾小球增大和局灶节段肾小球硬化;电镜结果符合肾小球基底膜节段性增厚。血管紧张素转换酶抑制剂(ACEI)治疗可减少 24 小时尿蛋白排泄。

结论

我们报告了首例 FPLD4 患者的蛋白尿和肾活检病例。基因分析显示该患者及其母亲的 PLIN1 中存在新型杂合性移码突变。ACEI 治疗证明是有益的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b7d/5946515/ea878e48ecd0/12882_2018_913_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b7d/5946515/ffaf5e6ee1fa/12882_2018_913_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b7d/5946515/2cc43c0a7213/12882_2018_913_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b7d/5946515/54b20016c51f/12882_2018_913_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b7d/5946515/445f5af85f71/12882_2018_913_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b7d/5946515/ea878e48ecd0/12882_2018_913_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b7d/5946515/ffaf5e6ee1fa/12882_2018_913_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b7d/5946515/2cc43c0a7213/12882_2018_913_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b7d/5946515/54b20016c51f/12882_2018_913_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b7d/5946515/445f5af85f71/12882_2018_913_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b7d/5946515/ea878e48ecd0/12882_2018_913_Fig5_HTML.jpg

相似文献

1
The renal manifestations of type 4 familial partial lipodystrophy: a case report and review of literature.4 型家族性部分性脂肪营养不良的肾脏表现:病例报告及文献复习。
BMC Nephrol. 2018 May 10;19(1):111. doi: 10.1186/s12882-018-0913-6.
2
Diagnostic Challenge in PLIN1-Associated Familial Partial Lipodystrophy.PLIN1 相关家族性部分脂肪营养不良的诊断挑战。
J Clin Endocrinol Metab. 2019 Dec 1;104(12):6025-6032. doi: 10.1210/jc.2019-00849.
3
A new type of familial partial lipodystrophy: distinctive fat distribution and proteinuria.一种新型家族性部分脂肪营养不良:独特的脂肪分布和蛋白尿。
Endocr Res. 2018 Nov;43(4):258-263. doi: 10.1080/07435800.2018.1470188. Epub 2018 May 7.
4
Podocytopathies associated with familial partial lipodystrophy due to LMNA variants: report of two cases.与 LMNA 变异相关的家族性部分脂肪营养不良的足细胞病:两例报告。
Arch Endocrinol Metab. 2024 May 10;68:e230204. doi: 10.20945/2359-4292-2023-0204.
5
Clinical and molecular characterization of a novel PLIN1 frameshift mutation identified in patients with familial partial lipodystrophy.在家族性部分脂肪营养不良患者中鉴定出的一种新型PLIN1移码突变的临床和分子特征
Diabetes. 2015 Jan;64(1):299-310. doi: 10.2337/db14-0104. Epub 2014 Aug 11.
6
Cosegregation of focal segmental glomerulosclerosis in a family with familial partial lipodystrophy due to a mutation in LMNA.由于 LMNA 基因突变导致家族性部分脂肪营养不良的一家系中局灶节段性肾小球硬化的共分离。
Nephron Clin Pract. 2013;124(1-2):31-7. doi: 10.1159/000354716. Epub 2013 Sep 26.
7
Fitting the pieces of the puzzle together: a case report of the Dunnigan-type of familial partial lipodystrophy in the adolescent girl.拼凑拼图碎片:一名青春期女孩的邓尼根型家族性部分脂肪营养不良病例报告
BMC Pediatr. 2016 Mar 14;16:38. doi: 10.1186/s12887-016-0581-2.
8
Familial partial lipodystrophy associated with the heterozygous LMNA mutation 1445G>A (Arg482Gln) in a Polish family.波兰一个家族中杂合子 LMNA 突变 1445G>A(Arg482Gln)与家族性部分脂肪营养不良相关。
Neurol Neurochir Pol. 2010 May-Jun;44(3):291-6. doi: 10.1016/s0028-3843(14)60044-x.
9
A case of Dunnigan-type familial partial lipodystrophy (FPLD) due to lamin A/C (LMNA) mutations complicated by end-stage renal disease.一例因核纤层蛋白A/C(LMNA)突变导致的邓尼根型家族性部分脂肪营养不良(FPLD)并发终末期肾病。
Endocrine. 2009 Feb;35(1):18-21. doi: 10.1007/s12020-008-9127-1. Epub 2008 Nov 15.
10
Type 1 familial partial lipodystrophy: understanding the Köbberling syndrome.1型家族性部分脂肪营养不良:认识科贝林综合征。
Endocrine. 2016 Nov;54(2):411-421. doi: 10.1007/s12020-016-1002-x. Epub 2016 Jul 30.

引用本文的文献

1
Severe Insulin Resistance Syndromes: Clinical Spectrum and Management.严重胰岛素抵抗综合征:临床谱与管理
Int J Mol Sci. 2025 Jun 13;26(12):5669. doi: 10.3390/ijms26125669.
2
Lipid metabolism disorder in diabetic kidney disease.糖尿病肾病中的脂代谢紊乱。
Front Endocrinol (Lausanne). 2024 Apr 29;15:1336402. doi: 10.3389/fendo.2024.1336402. eCollection 2024.
3
Kidney lipid dysmetabolism and lipid droplet accumulation in chronic kidney disease.慢性肾脏病中的肾脏脂质代谢紊乱和脂滴积累。

本文引用的文献

1
Focal Segmental Glomerulosclerosis.局灶节段性肾小球硬化症
Clin J Am Soc Nephrol. 2017 Mar 7;12(3):502-517. doi: 10.2215/CJN.05960616. Epub 2017 Feb 27.
2
Clinical Features and Management of Non-HIV-Related Lipodystrophy in Children: A Systematic Review.儿童非HIV相关脂肪代谢障碍的临床特征与管理:一项系统综述
J Clin Endocrinol Metab. 2017 Feb 1;102(2):363-374. doi: 10.1210/jc.2016-2271.
3
Lipodystrophy Syndromes.脂肪营养不良综合征。
Nat Rev Nephrol. 2023 Oct;19(10):629-645. doi: 10.1038/s41581-023-00741-w. Epub 2023 Jul 27.
4
Hereditary severe insulin resistance syndrome: Pathogenesis, pathophysiology, and clinical management.遗传性严重胰岛素抵抗综合征:发病机制、病理生理学及临床管理
Genes Dis. 2022 Apr 11;10(5):1846-1856. doi: 10.1016/j.gendis.2022.03.016. eCollection 2023 Sep.
5
Case report: Focal segmental glomerulosclerosis in a pediatric atypical progeroid syndrome.病例报告:小儿非典型早老综合征中的局灶节段性肾小球硬化症
Front Pediatr. 2022 Oct 31;10:1032653. doi: 10.3389/fped.2022.1032653. eCollection 2022.
6
New insights into renal lipid dysmetabolism in diabetic kidney disease.糖尿病肾病中肾脏脂质代谢异常的新见解。
World J Diabetes. 2021 May 15;12(5):524-540. doi: 10.4239/wjd.v12.i5.524.
7
Severe insulin resistance syndromes.严重胰岛素抵抗综合征。
J Clin Invest. 2021 Feb 15;131(4). doi: 10.1172/JCI142245.
8
Diagnostic Challenge in PLIN1-Associated Familial Partial Lipodystrophy.PLIN1 相关家族性部分脂肪营养不良的诊断挑战。
J Clin Endocrinol Metab. 2019 Dec 1;104(12):6025-6032. doi: 10.1210/jc.2019-00849.
Endocrinol Metab Clin North Am. 2016 Dec;45(4):783-797. doi: 10.1016/j.ecl.2016.06.012. Epub 2016 Oct 6.
4
The Diagnosis and Management of Lipodystrophy Syndromes: A Multi-Society Practice Guideline.脂肪营养不良综合征的诊断与管理:多学会实践指南
J Clin Endocrinol Metab. 2016 Dec;101(12):4500-4511. doi: 10.1210/jc.2016-2466. Epub 2016 Oct 6.
5
Clinical Utility Gene Card for: Familial partial lipodystrophy.家族性部分脂肪营养不良的临床应用基因卡片
Eur J Hum Genet. 2017 Feb;25(2). doi: 10.1038/ejhg.2016.102. Epub 2016 Aug 3.
6
Clinical and molecular characterization of a novel PLIN1 frameshift mutation identified in patients with familial partial lipodystrophy.在家族性部分脂肪营养不良患者中鉴定出的一种新型PLIN1移码突变的临床和分子特征
Diabetes. 2015 Jan;64(1):299-310. doi: 10.2337/db14-0104. Epub 2014 Aug 11.
7
A potential role for mechanical forces in the detachment of podocytes and the progression of CKD.机械力在足细胞脱离及慢性肾脏病进展中的潜在作用。
J Am Soc Nephrol. 2015 Feb;26(2):258-69. doi: 10.1681/ASN.2014030278. Epub 2014 Jul 24.
8
Cosegregation of focal segmental glomerulosclerosis in a family with familial partial lipodystrophy due to a mutation in LMNA.由于 LMNA 基因突变导致家族性部分脂肪营养不良的一家系中局灶节段性肾小球硬化的共分离。
Nephron Clin Pract. 2013;124(1-2):31-7. doi: 10.1159/000354716. Epub 2013 Sep 26.
9
FAT SIGNALS--lipases and lipolysis in lipid metabolism and signaling.脂肪信号——脂质代谢和信号转导中的脂肪酶和脂肪分解。
Cell Metab. 2012 Mar 7;15(3):279-91. doi: 10.1016/j.cmet.2011.12.018.
10
Glomerular hyperfiltration: definitions, mechanisms and clinical implications.肾小球高滤过:定义、机制与临床意义。
Nat Rev Nephrol. 2012 Feb 21;8(5):293-300. doi: 10.1038/nrneph.2012.19.